December 8, 2022
FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits
Editor's Note
The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious.
The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19.
The recall was initiated because the kits were distributed to US customers without authorization, clearance, or approval by the FDA.
Distribution dates were May 2020 to January 2022.
Free Daily News
- Session: Anchors Away: 5 Strategies to Right-Size Your Inventory and Improve Supply Contracts
- Closing Keynote: Trimming the Sails: Improving Perioperative Efficiency by Managing Same-Day Admission Transitions
- Session: Navigating the Storm: Ensuring Operational Continuity Through Crisis Leadership
- Session: Cracking the Code: Innovative Hacks for Preference Card Management and C-Suite Support
- Session: Crew Incentives: 3 Guiding Principles to Leverage Value Analysis Teams
- Session: Course Correction—Negotiating Payor Rates in the ASC Setting
- Session: Modernizing OR Scheduling—How Northwell Health Streamlined Block Management
- Session: Anchoring Profits—Restructuring Inventory Practices to Secure $200 Million in Cost Savings
- Session: All Hands-on-Deck—How to Justify Your Staffing Needs and FTEs
- Session: Setting Sail—Top 5 Business Trends for Ambulatory Surgery Centers in 2025
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement